C.R. Bard (NYSE:BCR) revealed a 1-2 punch today when it reported another loss in its patent infringement war with W.L. Gore & Assoc. and an adverse insurance decision that could cost it $25 million.
Recalls
Hospira recalls contaminated saline solution
More claims that J&J knew of hip implant troubles long before issuing a recall
Will another Durata failure report drag St. Jude down?
Wall Street didn’t move much on news of another insulation-related failure in St. Jude Medical’s (NYSE:STJ) next-generation Durata defibrillator leads this week.
FDA makes Vascular Solutions’ catheter valve recall Class I
The FDA slapped its most serious designation on the recall of hemostasis valves made by Vascular Solutions (NSDQ:VASC).
The Minneapolis-based company last month recalled its Guardian II and Guardian II NC valves "due to a risk that air may be introduced into the device which may lead to an air embolism," according to the federal watchdog agency.
Recall: Spacelabs Healthcare pulls anesthesia workstations over excess CO2 risk
Washington-based Spacelabs Healthcare recalled a slate of its Spacelabs BleaseSirius and BleaseFocus anesthesia workstations as well as certain absorbers contained in service kits over concerns that they may contain a defect which could result in excess carbon dioxide in the gas delivered to a patient.
FDA puts highest-risk category on Symbios infusion pump recall
Symbios Medical Products recalled certain lots of its GOPump Elastomeric Infusion PumpKit systems over concerns that a component that moderates the flow of medicine from the pump may fail and cause an overdose.
The FDA placed Class I status on the recall, a category reserved for issues which "may cause serious adverse health consequences, including death," according to an agency notice.
FDA blames poor training for new deaths, injuries tied to Stryker’s recalled Neptune systems
J&J faces 2nd trial in in recalled hip controversy | MassDevice.com On Call
MASSDEVICE ON CALL — Healthcare giant Johnson & Johnson (NYSE:JNJ) denied claims this month in the 2nd of tens of thousands of patient injury lawsuits over its implanted metal-on-metal hips.
FLASH: Jury deems J&J’s DePuy ASR XL hip implant defective in design, orders $8.3M in damages
A California jury ruled against Johnson & Johnson (NYSE:JNJ) and its DePuy subsidiary in finding that the company’s ASR XL metal-on-metal hip implant was defectively designed.
Ad-Tech brain implant recall gets FDA’s highest-risk status | MassDevice.com On Call
MASSDEVICE ON CALL — Federal healthcare regulators gave Ad-Tech Medical Instrument Corp.’s wide-reaching brain implant recall Class I status, the highest-risk category for medical device recalls.
Late last year the Wisconsin-based medical device maker recalled its Macro Micro Subdural Electrodes over concerns that the implanted devices could cause damage to the brain.